Citigroup’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2K | Buy |
4,572
+3,547
| +346% | +$26.5K | ﹤0.01% | 4204 |
|
|
2025
Q1 | $10K | Buy |
+1,025
| New | +$10K | ﹤0.01% | 4424 |
|
|
2024
Q4 | – | Sell |
-8,887
| Closed | -$55.9K | – | 4997 |
|
|
2024
Q3 | $55.9K | Buy |
8,887
+4,004
| +82% | +$25.2K | ﹤0.01% | 4211 |
|
|
2024
Q2 | $30.9K | Buy |
4,883
+3,501
| +253% | +$22.2K | ﹤0.01% | 4115 |
|
|
2024
Q1 | $11.3K | Buy |
1,382
+274
| +25% | +$2.25K | ﹤0.01% | 4415 |
|
|
2023
Q4 | $9.24K | Buy |
1,108
+1,103
| +22,060% | +$9.2K | ﹤0.01% | 4446 |
|
|
2023
Q3 | $65 | Sell |
5
-2,034
| -100% | -$26.4K | ﹤0.01% | 4725 |
|
|
2023
Q2 | $32.6K | Buy |
+2,039
| New | +$32.6K | ﹤0.01% | 4150 |
|